Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> AMGEN Latest News

DEC 06, 2013 - Benzinga

A Must Read - Share

UPDATE: Citigroup Reiterates on Amgen Following Detailed Market Analysis

In a report published Friday, Citigroup analyst Yaron Werber reiterated a Buy rating on Amgen (NASDAQ: AMGN), but lowered the price target from $139.00 to $131.00. In the report, Citigroup noted, “We conducted a detailed analysis of the myeloma market and conclude that Kyprolis/oprozomib are facing tremendous long-term headwinds t

Tags: UPDATE: Citigroup Reiterates on Amgen Following Detailed Market Analysis,  Amgen Latest News